TSXV: FIRE
TORONTO, Nov. 24, 2017 /CNW/ - Supreme Pharmaceuticals
Inc. ("Supreme" or the "Company") (TSXV: FIRE) is
pleased to announce it has entered into a Letter of Intent ("LOI")
with the Alliance of Beverage Licensees ("ABLE BC"), the advocacy
organization representing BC's private liquor industry.
"We are pleased to partner with Supreme as our first licensed
producer and supplier for our retail members," said Jeff Guignard, Executive Director of ABLE BC.
"British Columbians have a keen awareness and appreciation for
exceptional cannabis, as such it was important to select an
organization devoted to cultivating premium cannabis at-scale. We
are confident Supreme's product offerings are what our adult-use
consumers are looking for."
ABLE BC agrees to provide Supreme with unique channels of
exposure to its more than 1,000 members consisting of private
liquor stores, neighborhood pubs, bars/nightclubs and hotel liquor
licensees.
John Fowler, CEO of Supreme
commented, "We are excited to work with ABLE BC and begin a
dialogue with their 1,000 members. We feel strongly our focus on
premium dried cannabis flower will be a differentiating factor for
Supreme in the adult-use market, particularly in BC's
quality-focused consumer market."
John Fowler, CEO and Director
About Supreme
Supreme is a Canadian publicly traded company committed to
becoming a leading cultivator and distributor of sun grown cannabis
through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally
licensed producer of medical cannabis pursuant to the ACMPR
operating inside a 342,000 sq. ft. facility. The facility combines
the best technology of indoor production with the efficiencies and
sustainability of a greenhouse, in a single large-format production
footprint. Please visit www.supreme.ca and www.7acres.com for more
information.
Forward Looking Statements
Certain statements made in this press release may constitute
forward-looking information under applicable securities laws. These
statements may relate to anticipated events or results and
include, but are not limited to, expectations regarding the
Offering, the use of proceeds and other statements that are not
historical facts. Particularly, information regarding our
expectations of future results, targets, performance achievements,
prospects or opportunities is forward-looking information. Often,
but not always, forward-looking statements can be identified by the
use of forward-looking terminology such as "may" "will", "expect",
"believe", "estimate", "plan", "could", "should", "would",
"outlook", "forecast", "anticipate", "foresee", "continue" or the
negative of these terms or variations of them or similar
terminology. Forward-looking statements are current as of the date
they are made and are based on applicable estimates and assumptions
made by us at the relevant time in light of our experience and
perception of historical trends, current conditions and expected
future developments, as well as other factors that we believe are
appropriate and reasonable in the circumstances. However, we do not
undertake to update any such forward-looking information whether as
a result of new information, future events or otherwise, except as
required under applicable securities laws in Canada. There can be no assurance that such
estimates and assumptions will prove to be correct. Many
factors could cause our actual results, level of activity,
performance or achievements or future events or developments to
differ materially from those expressed or implied by the
forward-looking statements, including, without limitation, the
factors discussed in the "Risks and Uncertainties" section of the
Company's Management's Discussion & Analysis dated October 27, 2017 ("MD&A"). A copy of the
MD&A and the Company's other publicly filed documents can be
accessed under the Company's profile on the System for Electronic
Document Analysis and Retrieval ("SEDAR") at www.sedar.com. The
Company cautions that the list of risk factors and uncertainties
described in the MD&A is not exhaustive and other factors could
also adversely affect its results. Readers are urged to consider
the risks, uncertainties and assumptions carefully in evaluating
the forward-looking information and are cautioned not to place
undue reliance on such information.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Supreme Pharmaceuticals Inc.